Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:10672041:1782 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:10672041:1782?format=raw |
LEADER: 01782cam a2200349 4500
001 4010323
005 20221027015421.0
008 701109s1970 paua b 100 0 eng
010 $a 73131190
020 $a0803605951
035 $a(OCoLC)ocm00102986
035 $9AJV8337HS
035 $a(NNC)4010323
035 $a4010323
040 $aDLC$cDLC$dVET$dZCH
050 00 $aRC382$b.L35
082 0 $a616.8/33/061
245 00 $aL-Dopa and Parkinsonism /$cEdited by André Barbeau [and] Fletcher H. McDowell.
260 $aPhiladelphia :$bF. A. Davis Co.,$c[1970]
300 $a433 pages :$billustrations ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aProceedings of the 1st of a series of meetings, held Nov. 9-11, 1969 at Val David; proceedings of the 2d are entered under: Canadian-American Conference on Parkinson's Disease, 2d, Princeton, N.J., 1973.
504 $a"Selected bibliography on L-Dopa, dopamine, and Parkinsonism, prepared by André Barbeau and Nicole Guay": p. [419]-433. Includes bibliographical references.
650 0 $aDopa$vCongresses.
650 0 $aParkinson's disease$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2010105130
650 2 $aDihydroxyphenylalanine$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D004295Q000627
650 2 $aParkinson Disease$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D010300Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBarbeau, André,$eeditor.$4http://id.loc.gov/vocabulary/relators/edt$0http://id.loc.gov/authorities/names/n79055373
700 1 $aMcDowell, Fletcher H.,$d1923-$eeditor.$4http://id.loc.gov/vocabulary/relators/edt$0http://id.loc.gov/authorities/names/n79097349
852 00 $boff,hsl$hRC382$i.L45 1970